6-K
NEWKamada Declares Cash Dividend of $0.14 Per Share
6-K
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026
6-K
Kamada Expands Biosimilar Portfolio in Israel with Launch of Two New Products
6-K
Kamada Ltd. Responds to SEC Comments on Form 20-F Regarding Inventory Accounting Policies
6-K
Kamada Confirms Sufficient KedRAB Supply and Manufacturing Capacity to Meet Increased U.S. Demand
6-K
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
